S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
OTCMKTS:RHHVF

Roche (RHHVF) Stock Price, News & Analysis

$264.02
+7.02 (+2.73%)
(As of 02/27/2024 ET)
Today's Range
$261.20
$264.85
50-Day Range
$252.91
$298.96
52-Week Range
$252.87
$323.78
Volume
1,068 shs
Average Volume
4,990 shs
Market Capitalization
N/A
P/E Ratio
24.42
Dividend Yield
2.95%
Price Target
N/A

Roche MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.34mentions of Roche in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.13 out of 5 stars


RHHVF stock logo

About Roche Stock (OTCMKTS:RHHVF)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

RHHVF Stock Price History

RHHVF Stock News Headlines

Roche (OTCMKTS:RHHVF) Shares Up 2.7%
Roche Holding AG (RHHVF) Gets a Hold from Jefferies
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Roche: The Recent Sell-Off Created A 30% Upside Potential
Roche Holding AG
Barclays Keeps Their Hold Rating on Roche Holding AG (RHHVF)
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Roche Holding AG Participation (RHHVF)
Roche Holding AG Participation (RHHVF)
Roche: Leveraging Nvidia's AI For Genentech's Innovation
See More Headlines
Receive RHHVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:RHHVF
CIK
N/A
Fax
N/A
Employees
103,605
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Severin Schwan Ph.D. (Age 57)
    Executive Chairman
    Comp: $8.52M
  • Dr. Thomas Schinecker (Age 49)
    Chief Executive Officer
    Comp: $4.39M
  • Dr. Alan Hippe (Age 57)
    Chief Financial & Information Officer
    Comp: $4.66M
  • Dr. Bruno Eschli
    Head of Investor Relations
  • Ms. Claudia Bockstiegel (Age 60)
    General Counsel
  • Ms. Pascale Schmidt (Age 51)
    Chief Compliance Officer
  • Ms. Barbara Schadler (Age 62)
    Head of Group Communications
  • Ms. Cristina A. Wilbur (Age 57)
    Chief People Officer
    Comp: $3.31M
  • Dr. Nicolas Dunant
    Head of Group Media Relations
  • Mr. Boris L. Zaitra (Age 52)
    Head of Group Business Development and M&A














RHHVF Stock Analysis - Frequently Asked Questions

How have RHHVF shares performed in 2024?

Roche's stock was trading at $285.00 on January 1st, 2024. Since then, RHHVF stock has decreased by 7.4% and is now trading at $264.02.
View the best growth stocks for 2024 here
.

Is Roche a good dividend stock?

Roche (OTCMKTS:RHHVF) pays an annual dividend of $7.80 per share and currently has a dividend yield of 3.21%. The dividend payout ratio is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Roche?

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RHHVF) was last updated on 2/28/2024 by MarketBeat.com Staff